Allworth Financial LP Corcept Therapeutics Inc Transaction History
Allworth Financial LP
- $17.4 Billion
- Q1 2025
A detailed history of Allworth Financial LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Allworth Financial LP holds 51 shares of CORT stock, worth $3,770. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 21
142.86%
Holding current value
$3,770
Previous $1,000
400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CORT
# of Institutions
438Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$738 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$599 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$458 Million0.49% of portfolio
-
Parallel Advisors, LLC3.97MShares$294 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.92B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...